News
Disney World's Top Rival Tries to Scare Its Way to the Top
Halloween is a special time of year for Comcast's (NASDAQ: CMCSA) Universal Orlando. Halloween Horror Nights 27 kicks off tonight, greeting as many as tens of thousands of guests on select event....
Better Buy: Infinera Corporation vs. Ciena Corporation
Infinera (NASDAQ: INFN) and Ciena (NYSE: CIEN) were both market laggards this year, with the former staying nearly flat and the latter dropping almost 10%. Both optical transport solution....
After iPhone X, What’s Next for Apple Inc. Stock?
Now that Apple (NASDAQ: AAPL) has finally announced its highly anticipated iPhone X smartphone, current and potential investors in Apple are probably keenly interested in where the stock will head....
Here's Why Higher Interest Rates Matter to JPMorgan Chase
Interest rates are one of the most important catalysts for bank stocks right now, with higher rates promising improved profitability throughout the industry. Given that the Federal Reserve will....
Apple Inc. May Have Finally Solved a Big iPhone X Production Problem
On Sept. 12, Apple (NASDAQ: AAPL) unveiled its new iPhone X (pronounced "iPhone 10") smartphone. The device is Apple's best -- and most premium -- smartphone to date, sporting a nifty 3D sensing....
Pfizer Punches Back at Johnson & Johnson in Prostate Cancer
After winning Food and Drug Administration (FDA) approval for use in castration-resistant metastatic prostate cancer in 2012, Pfizer's (NYSE: PFE) Xtandi quickly gained ground on Johnson &....
3 Value Stocks for Nest-Egg Growth
Stock investing can be volatile, creating short-term risk. But if you invest in stocks at their best value points, you can reduce some of the risk and set yourself up for better long-term returns.....
3 High-Yield Stocks Still Worth Buying
High yields on a stock can often be a warning sign for investors, indicating the market doesn't think the high payout will last long. But the market can sometimes assign too much risk to....
2 Features to Expect From Apple Inc.’s Next iPhone X
On Sept. 12, Apple (NASDAQ: AAPL) finally unveiled its long-awaited premium iPhone, which we now know is called the iPhone X. The phone is -- at least from what I've seen from Apple's....
Who Will Win the Kidney Cancer Battle Between Bristol-Myers Squibb and Exelixis?
A head-to-head competition for market share in the renal cell carcinoma (RCC) market appears to be about to intensify. In one corner is Bristol-Myers Squibb (NYSE: BMY). With a market cap of over....
These 2 Big Oil Stocks Are Ridiculously Cheap...Again
Back when oil prices started to climb out from the abyss in February of 2016, it would have been reasonable to think that oil and gas stocks wouldn't get that cheap ever again. That is especially....
7 Things the Samsung Galaxy S8 Has That the New iPhone X Doesn't
Image source: Samsung.Apple (NASDAQ: AAPL) just unveiled the much-anticipated iPhone X (pronounced "iPhone 10"). It represents the next leap forward for Apple with its all-screen design, Face ID....
3 Tech Stocks You Can Buy on Sale Now
Sometimes, even well-respected stalwarts of industry wind up in Wall Street's bargain bin. The question for long-term investors is whether they belong there.Case in point: IBM (NYSE: IBM), Intel....
Good News: Apple Has Ruined Its Numbered iPhone Naming Convention
I'm not a fan of numbered iPhones. The naming convention wore out its welcome a long time ago; Apple (NASDAQ: AAPL) just somehow hasn't realized it yet. Using numbers is simply unsustainable and....
3 Value Stocks to Dive Into Now
It's not always easy to distinguish great value investments from failing businesses. Many of their features are often the same, and the attributes that will turn some such companies into long-term....
3 Top E-Commerce Companies to Buy in 2017
No discussion of e-commerce can take place without mentioning the mighty Amazon.com (NASDAQ: AMZN). The company dominates online retail -- and, increasingly -- retail as a whole.Yet there are....
Should You Buy Apple Shares After the iPhone X Launch?
Apple's (NASDAQ: AAPL) iPhone X has been so hyped up that CEO Tim Cook said in May that iPhone sales were lower because customers were holding out for this 10th-anniversary edition of the....
Why Apple Finally Embraced Dolby Vision
Thanks to Apple (NASDAQ: AAPL), it's been a great week for Dolby Laboratories (NYSE: DLB) investors. Dolby shares are up more than 15% over the past four days, including a nearly 10% pop on....
Hate Risk? You'll Love These 3 Stocks
Risk is unavoidable -- however, several stocks have positioned themselves in a way that still offers growth potential while mitigating risk, unlike high-growth stocks that are years away from....
3 Dividend Stocks Ideal for Retirees
If you're near or in retirement, owning dividend stocks can be a great way to create a consistent stream of cash flows to fund your living expenses or even travel the world. But not all dividends....
3 Value Stocks for Conservative Investors
Value can be measured in a lot of ways, depending on the nature of the company you're analyzing. A low price-to-earnings (P/E) ratio may be a good measure, book value may be used, or sometimes,....
Apple, Inc.'s Epic Face ID Fail: Not a Fail After All?
If you were watching the live stream, you probably cringed. The very first action performed on Apple's (NASDAQ: AAPL) new iPhone X totally -- and embarrassingly -- failed during Apple's Sept. 12....
Apple, Inc.'s iPhone X Event: What Analysts Are Saying
While the media seems to have mixed feelings about Apple's (NASDAQ: AAPL) new $999 iPhone X, there's less disparity among analysts. Overall, analysts seem optimistic after Apple's Sept. 12....
When Will ExxonMobil Corporation Split Its Stock Again?
Oil giant ExxonMobil (NYSE: XOM) is no stranger to stock splits, having completed seven of them over the course of its history. Many of those occurred after its stock price had risen into the....
Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale
Take your seats, investors: The battle in first-line advanced renal cell carcinoma, the most common type of kidney cancer, is about to begin.In one corner, weighing in at a market cap of $8....